
A U.S. federal judge has rejected challenges by two pharmaceutical manufacturers seeking to block a Maine law that regulates the use of contract pharmacies under the federal 340B drug discount program.
Novartis AG (NYSE:NVS) and AbbVie Inc. (NYSE:ABBV) argued the statute conflicted with federal law and violated constitutional provisions, but the court disagreed.